Editorial: coeliac disease follow-up guided by gluten immunogenic peptides-are we there yet? Authors' reply.

Autor: Garzón-Benavides M; Digestive Disease Clinical Unit and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío Hospital/CSIC/US, Seville, Spain., Rodríguez-Herrera A; Saint Luke's General Hospital, Kilkenny, Ireland., Sousa C; Department of Microbiology and Parasitology, Faculty of Pharmacy, University of Seville, Seville, Spain., Pizarro-Moreno A; Digestive Disease Clinical Unit and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío Hospital/CSIC/US, Seville, Spain.

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Jun; Vol. 57 (11), pp. 1341-1342.

Clinical utility of urinary gluten immunogenic peptides in the follow-up of patients with coeliac disease.

Autor: Garzón-Benavides M; Digestive Disease Clinical Unit. and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío Hospital/CSIC/US, Seville, Spain., Ruiz-Carnicer Á; Department of Microbiology and Parasitology, Faculty of Pharmacy, University of Seville, Seville, Spain., Segura V; Department of Microbiology and Parasitology, Faculty of Pharmacy, University of Seville, Seville, Spain., Fombuena B; Digestive Disease Clinical Unit. and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío Hospital/CSIC/US, Seville, Spain., García-Fernandez F; Digestive Disease Clinical Unit. and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío Hospital/CSIC/US, Seville, Spain., Sobrino-Rodriguez S; Digestive Disease Clinical Unit. and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío Hospital/CSIC/US, Seville, Spain., Gómez-Izquierdo L; Pathology Service, Virgen del Rocío Hospital, Seville, Spain., Montes-Cano MA; Inmunology Service, CIBER of Epidemiology and Public Health, Virgen del Rocío Hospital /IBiS/CSIC/University of Seville, Seville, Spain., Millan-Domínguez R; Digestive Disease Clinical Unit. and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío Hospital/CSIC/US, Seville, Spain., Del Carmen Rico M; Digestive Disease Clinical Unit. and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío Hospital/CSIC/US, Seville, Spain., González-Naranjo C; Digestive Disease Clinical Unit. and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío Hospital/CSIC/US, Seville, Spain., Bozada-García JM; Digestive Disease Clinical Unit. and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío Hospital/CSIC/US, Seville, Spain., Coronel-Rodríguez C; Health Center Amante Laffón, Seville, Spain., Espin B; Pediatric, Gastroenterology, Hepatology and Nutrition Section, Virgen del Rocio Children's Hospital, Seville, Spain., Díaz J; Clinical Analysis Service, Hospital Universitario INGESA, Ceuta, Spain., Comino I; Department of Microbiology and Parasitology, Faculty of Pharmacy, University of Seville, Seville, Spain., Argüelles-Arias F; Digestive Diseases Clinical Unit, Virgen Macarena Hospital, Seville, and University of Seville, Seville, Spain., Cebolla Á; Biomedal S.L., Seville, Spain., Romero-Gómez M; Digestive Disease Clinical Unit. and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío Hospital/CSIC/US, Seville, Spain., Rodriguez-Herrera A; Saint Luke's General Hospital, Kilkenny, Ireland., Sousa C; Department of Microbiology and Parasitology, Faculty of Pharmacy, University of Seville, Seville, Spain., Pizarro-Moreno Á; Digestive Disease Clinical Unit. and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío Hospital/CSIC/US, Seville, Spain.

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 May; Vol. 57 (9), pp. 993-1003. Date of Electronic Publication: 2023 Mar 08.

What is the Role of Measuring Urinary Gluten Immunogenic Peptides in Clinical Practice in Patients with Coeliac Disease?

Autor: Raju, Suneil A.^1,2 suneilraju@gmail.com, Ingham, Katerina E.^1,2, Green, Olivia^1,2, Johnson, Calvin M.^1,2, Shiha, Mohamed G.^1,2, Nandi, Nicoletta^1,2, Trott, Nick^1,2, Penny, Hugo A.^1,2, Hadjivassiliou, Marios³, Wild, Graeme⁴, Sanders, David S.^1,2

Publikováno v: Journal of Gastrointestinal & Liver Diseases. Dec2024, Vol. 33 Issue 4, p482-487. 6p.

Papel del tratamiento endovascular en la isquemia mesentérica crónica

Autor: Pizarro-Moreno, A., Araujo Miguez, A., Garzón Benavides, M., Nacarino, V.

Publikováno v: In Revista clinica espanola 2012 212(8):416-418

Andalusian Registry for Familial Adenomatous Polyposis: Analysis of patients included

Autor: Garzón Benavides, M., Pizarro Moreno, A., García Lozano, R., Herrero Garrido, M. I., Hervás Molina, A. J., Márquez Galán, J. L., Cordero Fernandez, C.

Publikováno v: Revista Española de Enfermedades Digestivas, Volume: 102, Issue: 11, Pages: 653-657, Published: NOV 2010

Objective: To evaluate the phenotype and genotype characteristic of patients included in the Andalusian Registry for familial adenomatous polyposis, the genotype/phenotype correlation and the impact of Registry in the frequency of colorectal cancer o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______624::af6bf4b2741a4bb250988fa63eb15198
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082010001100006&lng=en&tlng=en